Lumexa Leader Joins RSNA Board to Advance Imaging Quality
Raleigh, N.C. | January 28, 2026 — Lumexa Imaging, one of the largest U.S. providers of outpatient diagnostic imaging...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Raleigh, N.C. | January 28, 2026 — Lumexa Imaging, one of the largest U.S. providers of outpatient diagnostic imaging...
VANCOUVER, BC — December 5, 2025 — TempraMed Technologies Ltd. announced a major expansion into Western Europe through a...
SOUTH ORANGE, N.J., November 6, 2025 — Nephros, Inc. (Nasdaq: NEPH), a leader in water filtration solutions for the...
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
